News by Subject
News by Disease
News by Date
Post Your News
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
US & Canada
Post an Event
News | News By Subject | News by Disease |
News By Date | Search News
8/13/2009 10:43:15 AM
August 12, 2009, CANTON,MA: Metabasis, a San Diego-based biotech company, is offering more than 500 pieces of state-of-the-art R&D equipment that is no longer essential to their ongoing operations. The firm has selected EquipNet as the exclusive seller and listed the premium lab and analytical equipment on the EquipNet MarketPlace™, the world’s largest online venue for pre-owned equipment.
Metabasis is a biotech firm, specializing in the development of drugs for the treatment of metabolic diseases such as hyperlipidemia and diabetes. As the foremost provider of surplus asset management sales and services, EquipNet is freeing up Metabasis to focus on their core business activities while providing buyers with a great opportunity to purchase NMRs, late model Agilent 1200 HPLCs, Mass Spectrometers, and other premium lab and analytical equipment.
“Companies that are upgrading their equipment or outfitting a new lab should take advantage of this chance to purchase high-end equipment at pre-owned prices,“ says Dennis Higgins, EquipNet’s Biotech Sales Leader. “I’ve never seen such a large selection of pieces in such fabulous condition.”
Identifying idle assets and recovering some of their value is an incredibly effective, money-saving strategy for many companies, particular in our current economy.
Being able to sell surplus equipment that’s just taking up space can generate much-needed revenue to fund current and future projects.
Specifications and photographs for the 500+ listings can be viewed at http://www.EquipNet.com/Metabasis. All equipment in this project is located at the Metabasis facility in the La Jolla section of San Diego.
EquipNet is a leading provider of proactive asset management solutions and services to leading corporations in the biotech, pharmaceutical, chemical, and consumer packaged goods industries, such as GlaxoSmithKline, AstraZeneca, Unilever, Merck, and many others. EquipNet's vision is to revolutionize the way companies manage their surplus assets by maximizing financial returns and minimizing the risks associated with idle capital assets. For more information, please visit: http://www.EquipNet.com.
Gregory Feinberg, EquipNet
(781) 821-3482, ext. 2106
Ben Potenza, EquipNet
(781) 821-3482, ext. 2180